42 results
8-K
EX-99.1
OCEL
Organicell Regenerative Medicine, Inc.
6 Jun 23
Private And Confidential. © 2023 Organicell Regenerative Medicine, Inc. All rights reserved. Investor Presentation June 2023 1
4:53pm
operate in a very competitive and rapidly - changing environment and new risks emerge from time to time . As a result, it is not possible for our
8-K
EX-99.1
y6v7nwr4xu2vdf5d18bj
9 Sep 22
Organicell Regenerative Medicine, Inc. Secures Additional $11 Million in Financing in Preparation for Clinical Trial Enrollment
8:30am
8-K
EX-10.1
u9dkzfrn47q aa
6 Sep 22
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-10.1
0ktvwq v0cjtlbdgol
23 Aug 22
Entry into a Material Definitive Agreement
4:51pm
8-K
EX-10.4
9ljl6c
23 Aug 22
Entry into a Material Definitive Agreement
4:51pm
8-K
EX-10.2
l3ct5vklz7sjms6m8
23 Aug 22
Entry into a Material Definitive Agreement
4:51pm
8-K
EX-10.3
zh67v
23 Aug 22
Entry into a Material Definitive Agreement
4:51pm